Author Correction: Genome-wide CRISPR-Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1.

Journal

Nature immunology
ISSN: 1529-2916
Titre abrégé: Nat Immunol
Pays: United States
ID NLM: 100941354

Informations de publication

Date de publication:
06 2020
Historique:
pubmed: 4 3 2020
medline: 4 3 2020
entrez: 4 3 2020
Statut: ppublish

Résumé

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiants

DOI: 10.1038/s41590-020-0640-6 PMID: 32123375
pubmed: 32123375
doi: 10.1038/s41590-020-0640-6
pii: 10.1038/s41590-020-0640-6
doi:

Types de publication

Journal Article Published Erratum

Langues

eng

Sous-ensembles de citation

IM

Pagination

695

Commentaires et corrections

Type : ErratumFor

Auteurs

Michael D Crowther (MD)

Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, UK.

Garry Dolton (G)

Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, UK.

Mateusz Legut (M)

Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, UK.

Marine E Caillaud (ME)

Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, UK.

Angharad Lloyd (A)

Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, UK.

Meriem Attaf (M)

Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, UK.

Sarah A E Galloway (SAE)

Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, UK.

Cristina Rius (C)

Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, UK.

Colin P Farrell (CP)

Division of Hematology, University of Utah School of Medicine, Salt Lake City, UT, USA.

Barbara Szomolay (B)

Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, UK.
Systems Immunity Research Institute, Cardiff University, Cardiff, UK.

Ann Ager (A)

Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, UK.
Systems Immunity Research Institute, Cardiff University, Cardiff, UK.

Alan L Parker (AL)

Division of Cancer and Genetics, Cardiff University School of Medicine, Cardiff, UK.
ORCID: 0000-0002-9302-1761

Anna Fuller (A)

Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, UK.

Marco Donia (M)

Center for Cancer Immune Therapy, Herlev Hospital, Copenhagen University, Copenhagen, Denmark.
ORCID: 0000-0003-4966-9752

James McCluskey (J)

Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Parkville, Victoria, Australia.
ORCID: 0000-0002-8597-815X

Jamie Rossjohn (J)

Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, UK.
Systems Immunity Research Institute, Cardiff University, Cardiff, UK.
Australian Research Council Centre of Excellence in Advanced Molecular Imaging, Monash University, Clayton, Victoria, Australia.
Infection and Immunity Program & Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.
ORCID: 0000-0002-2020-7522

Inge Marie Svane (IM)

Center for Cancer Immune Therapy, Herlev Hospital, Copenhagen University, Copenhagen, Denmark.

John D Phillips (JD)

Division of Hematology, University of Utah School of Medicine, Salt Lake City, UT, USA.

Andrew K Sewell (AK)

Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, UK. sewellak@cardiff.ac.uk.
Systems Immunity Research Institute, Cardiff University, Cardiff, UK. sewellak@cardiff.ac.uk.
ORCID: 0000-0003-3194-3135

Classifications MeSH